Sec Form 4 Filing - Palo Alto Investors LP @ ALIMERA SCIENCES INC - 2023-03-24

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Palo Alto Investors LP
2. Issuer Name and Ticker or Trading Symbol
ALIMERA SCIENCES INC [ ALIM]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
470 UNIVERSITY AVENUE
3. Date of Earliest Transaction (MM/DD/YY)
03/24/2023
(Street)
PALO ALTO, CA94301
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/24/2023 S 200,919 ( 1 ) D $ 1.5634 0 I See note ( 1 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Convertible Preferred Stock ( 2 ) 03/24/2023 S 600,000 10/01/2012 ( 2 ) Common Stock 601,502 $ 1.5634 0 I See note ( 1 )
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Palo Alto Investors LP
470 UNIVERSITY AVENUE
PALO ALTO, CA94301
X
Signatures
/s/ Angela Nguyen-Dinh, Chief Compliance Officer of Palo Alto Investors LP 03/28/2023
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Palo Alto Investors LP ("PAI") is the investment adviser to private funds, including Palo Alto Healthcare Master Fund, L.P. and Palo Alto Healthcare Master Fund II, L.P. (collectively, the "Funds"). Anthony Joonkyoo Yun, MD and Patrick Lee, MD are the managers and controlling owners of PAI. PAI may be deemed to indirectly beneficially own these securities as the investment adviser to the Funds. Dr. Yun and Dr. Lee may be deemed to indirectly beneficially own them as the control persons of PAI. No single Fund owns more than 10% of the outstanding shares of Common Stock. The reporting person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein.
( 2 )Each share of Series A Convertible Preferred Stock is convertible into shares of common stock at the rate equal to $40.00 divided by $39.90. The Series A Convertible Preferred Stock does not have an expiration date.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.